Browse current and past press releases from The Michael J. Fox Foundation.
- 
              
  Though Safe and Tolerable, Nilotinib Does Not Show Promise for Benefit in Phase II Nilotinib for Parkinson’s Disease (NILO-PD) Trial
 
- 
              
  Accelerating Medicines Partnership Launches Data Knowledge Portal for Parkinson’s Disease
 
- 
              
  Michael J. Fox Foundation Honors Antonio Pisani, MD, PhD, and David G. Standaert, MD, PhD, with Bachmann-Strauss Prize for Excellence in Dystonia Research
 
- 
              
  Michael J. Fox Foundation Honors Andrew Singleton, PhD, with Robert A. Pritzker Prize for Leadership in Parkinson's Research
 
- 
              
  The Michael J. Fox Foundation’s Edmond J. Safra Fellowship in Movement Disorders Selects Class of 2022
 
- 
              
  The Michael J. Fox Foundation and Massachusetts General Hospital Announce Initiative to Engage Underrepresented Populations in Parkinson’s Research
 
- 
              
  Michael J. Fox Foundation Announces $10-million “Ken Griffin Alpha-synuclein Imaging Competition” Spurring Development of Critical and Elusive Research Tool for Parkinson’s Disease